𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53

✍ Scribed by Hesham Basma; Hesham El-Refaey; Magdalene K. Sgagias; Kenneth H. Cowan; Xu Luo; Pi-Wan Cheng


Publisher
BioMed Central
Year
2005
Tongue
English
Weight
419 KB
Volume
12
Category
Article
ISSN
1021-7770

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Down-regulation of apoptosis-related bcl
✍ Besim Ogretmen; Ahmad R. Safa πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 797 KB

Recent studies have shown that high levels of the apoptosisrelated proteins bcl-2 and bcl-x, increase, while over-expression of bcl-x, or bax decreases, resistance to drugs that induce apoptosis in some human cancer cells. In the present report, we investigated whether expression of these apoptosis-

Erratum to Poso-Guisado et al., β€œResvera
πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 24 KB πŸ‘ 1 views

## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (2005) 115(1) 74–84 DOI: 10.1002/ijc.20856

Apoptotic response to camptothecin and 7
✍ Wilberto Nieves-Neira; Yves Pommier πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 263 KB πŸ‘ 2 views

Derivatives of camptothecins, topoisomerase I inhibitors and 7-hydroxystaurosporine (UCN-01), a protein kinase C (PKC) inhibitor and cell cycle checkpoint abrogator, are promising anticancer drugs. We characterized the apoptotic response to camptothecin and UCN-01 for the 8 human breast carcinoma ce